QUREBIO
QureBio focuses on the research and development of innovative macromolecular biopharmaceuticals. Its goal is to develop new therapeutic drugs for the treatment of refractory cancer, autoimmune diseases, and metabolic diseases in China and the world to benefit patients. QureBio has multiple technology platforms for antibody drug development including phage display technology platforms and hybridoma antibodies technology platform and monoclonal antibody platform. The company was founded in 2017 and is based in Pudong District, Shanghai.
QUREBIO
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2017-01-01
Address:
Shanghai, Shanghai, China
Country:
China
Total Employee:
101+
Status:
Active
Contact:
+86 136 2177 2640
Email Addresses:
[email protected]
Total Funding:
10 M CNY
Similar Organizations
Aprea
Aprea focuses on the discovery and development of novel anticancer compounds reactivating the tumor suppressor protein p53.
Bycen
Bycen does Research and development of human and animal behavior.
ComGen Biopharmaceutical
ComGen Biopharmaceutical is a researcher and developer of innovative drugs for immunotherapy of autoimmune diseases and tumors.
Frontier Biotechnologies
Frontier Biotechnologies is a commercial-stage bio-pharmaceutical company.
Guangdong Guofang Medical Technology
Guangdong Guofang Medical Technology is focused on the research and development of new pharmaceutical excipients.
Gynov
Gynov focuses on the development of innovative solutions dedicated to women's health issues.
HeRui BioMed
HeRui BioMed focuses on the development and industrialization of laboratory diagnostic technology.
Huvet Bio
Huvet Bio is engaged in the research and development of bio pharmaceuticals.
PHI BIOMED
PHI BIOMED offers the research and development of nanomedical and smart biomaterials products in contact lenses, serums, and proteins.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Qiyu Biotech
Qiyu Biotech is an innovative macromolecular drug developer.
Shanghai Henlius Biotech
Shanghai Henlius Biotech is joint venture company that provides clinical-stage biopharmaceutical services.
TechnoDerma Medicines
TechnoDerma Medicines focuses on the research and development of innovative skin drugs for external use.
Versameb
Versameb is focusing on the discovery and development of innovative, next-generation RNA-based drugs.
Current Employees Featured
Founder
Investors List
Shenzhen Capital Group
Shenzhen Capital Group investment in Series A - QureBio